Genetic Variability of HIV-1 for Drug Resistance Assay Development

A hybridization-based point-of-care (POC) assay for HIV-1 drug resistance would be useful in low- and middle-income countries (LMICs) where resistance testing is not routinely available. The major obstacle in developing such an assay is the extreme genetic variability of HIV-1. We analyzed 27,203 re...

Descripción completa

Detalles Bibliográficos
Autores principales: Clutter, Dana S., Sánchez, Patricia Rojas, Rhee, Soo-Yon, Shafer, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776203/
https://www.ncbi.nlm.nih.gov/pubmed/26875985
http://dx.doi.org/10.3390/v8020048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776203/
https://www.ncbi.nlm.nih.gov/pubmed/26875985
http://dx.doi.org/10.3390/v8020048

Ejemplares similares